Home > Quotes > NUE > Guru Analysis > Kenneth Fisher

Kenneth Fisher Guru Analysis for Nucor Corporation

Get NUE Alerts
*Delayed - data as of Mar. 26, 2015  -  Find a broker to begin trading NUE now
Exchange: NYSE
Industry: Basic Industries
Community Rating:
View:    NUE After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Assessments & Analysis Based on March 25, 2015 close price: $46.76

  for the Price/Sales Investor based on the criteria of Kenneth Fisher. Return to NUE Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 91%
Benjamin Graham 43%
Validea 7%
Motley Fool 25%
David Dreman 36%
Martin Zweig 62%
Kenneth Fisher 60%
James P. O'Shaughnessy 50%

Detailed Analysis

Guru Score: 60%


The prospective company should have a low Price/Sales ratio. Smokestack (cyclical) companies with a Price/Sales ratio between .4 and .8 represent good values according to this methodology. NUEpasses this test as its P/S of 0.71 Based on trailing 12 month sales, falls within the "good values" range for cyclical companies.


Less debt equals less risk according to this methodology. NUE's Debt/Equity of 60.37% is unacceptable, thus failing the test.


This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. NUE is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.

PRELIMINARY GRADE: No Interest in NUE At this Point

Is NUE a "Super Stock"? NO

Price/Sales Ratio: [PASS]

The Price/Sales ratio is the most important variable according to this methodology. The prospective company should have a low Price/Sales ratio. NUE's Price/Sales ratio of 0.71 passes this criterion.


This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. NUE's inflation adjusted EPS growth rate of 22.05% passes this test.


This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. NUE's free cash per share of 0.62 passes this criterion.


This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. NUE's three year net profit margin, which averages 2.85%, does not pass this criterion.

The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer
The Validea Market Legends ETF (VALX)